WallStreetZenWallStreetZen

NASDAQ: PRLD
Prelude Therapeutics Inc Stock Ownership - Who owns Prelude Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Prelude Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David P. BonitaDirector2026-04-211,689,189$4.44
$7.50MBuy
David P. BonitaDirector2026-04-211,126,126$4.44
$5.00MBuy
Orbimed Advisors LLCDirector2026-04-211,689,189$4.44
$7.50MBuy
Orbimed Advisors LLCDirector2026-04-211,126,126$4.44
$5.00MBuy

1 of 1

PRLD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRLD insiders and whales buy or sell their stock.

PRLD Shareholders

What type of owners hold Prelude Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC12.25%9,776,491$37.54MInsider
David P. Bonita12.25%9,776,491$37.54MInsider
Baker Bros Advisors LP11.59%9,252,951$35.53MInsider
Ra Capital Management LP9.88%7,882,882$30.27MInsider
Krishna Vaddi3.38%2,693,625$10.34MInsider
Paul A. Friedman0.63%500,098$1.92MInsider
Andrew Combs0.60%480,123$1.84MInsider
Peggy Scherle0.22%172,920$664.01kInsider
Sean P. Brusky0.13%100,000$384.00kInsider
Jane Huang0.11%86,917$333.76kInsider

1 of 3

PRLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRLD0.06%51.13%Net Buying
EIKN0.05%35.45%Net BuyingNet Buying
IRD0.02%99.98%Net SellingNet Buying
VOGX0.00%33.97%Net BuyingNet Buying
ENTA0.09%48.86%Net SellingNet Selling
View Top Biotech Stocks

Prelude Therapeutics Stock Ownership FAQ

Who owns Prelude Therapeutics?

Prelude Therapeutics (NASDAQ: PRLD) is owned by 0.06% institutional shareholders, 51.13% Prelude Therapeutics insiders, and 48.80% retail investors. Orbimed Advisors LLC is the largest individual Prelude Therapeutics shareholder, owning 9.78M shares representing 12.25% of the company. Orbimed Advisors LLC's Prelude Therapeutics shares are currently valued at $37.54M.

If you're new to stock investing, here's how to buy Prelude Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.